MannKind Completes Phase 1 Clinical Trial On Treprostinil

[Deleted]

MannKind (MNKD) announced today that it successfully completed a phase 1 clinical trial on a Treprostinil product for a proposed PAH treatment. The news of the trial completion came earlier than expected. The study was able to achieve its primary end point on both safety and tolerability. All doses in the study were successful. The company compared its results to Tyveso, a product that's currently marketed by Untited Therapeutics (UTHR).

MannKind listed the key highlights as the following:

Ability to deliver TreT within 1-2 inhalations in <10 seconds.
Maximum tolerated dose is expected to be able to deliver higher plasma concentrations above the reported data for the current commercially available inhaled treprostinil.
Based on these data, MannKind is preparing the next phase of development to evaluate the safety and tolerability of TreT in patients with PAH.
Data will be submitted to be presented at an upcoming conference.

seekingalpha.com/article/4180026-mannkind-completes-phase-1-clinical-trial-treprostinil-product

[awesomo]

The usual suspects of trash are all over the comment section already.

[Deleted]

I challenged Rising to put money where his mouth is; so far no comment.

[joeypotsandpans]

Jun 7, 2018 11:53:00 GMT -5 awesomo said:

The usual suspects of trash are all over the comment section already.

I see the street sweeper coming to whisk away the garbage on the street(s)

[brotherm1]

I thought that to be a nice article. Thank you Mr. Osborne

[brotherm1]

I view it as a very big step for MNKD

[lennymnkd]

How does one monitor what drugs have potential to be put on the PLATFORM/ molecule size I thought was one ! But would be nice to know a formula, so we can know what drugs ,pre clinical study’s we can hope for that have market potential.

[brentie]

MannKind (MNKD) Phase 1 Data Hints at ‘Transformational’ PAH Drug, Cheers H.C. Wainwright


www.smarteranalyst.com/analyst-insights/biotech-stocks/mannkind-mnkd-phase-1-data-hints-transformational-pah-drug-cheers-h-c-wainwright/

[sportsrancho]

Wow a two dollar price target, I don’t think I’m going to tweet that out.

[mnholdem]

The article (which I posted excerpts of in Articles) states that the PAH drug is not yet factored into that price target. 

[sportsrancho]

I guess that wasn’t my point, that’s Wainwright isn’t it...didn’t they just give us a five dollar price target, now they’re giving us a two dollar price target?

[awesomo]

My price target for 6/13/18 is $1.93. I'm fairly confident in this.

Also, this Oren Livnat has a terrible track record.

www.tipranks.com/analysts/oren-livnat